STAT3 and osteosarcoma: Using a drug-resistant osteosarcoma cell line, we showed that MSCs-induced STAT3 activation was similar to drug-induced STAT3 activation and that inhibition of STAT3 in both mice tumor models decreased tumor growth and prolonged overall survival.